Relapsed/Refractory Multiple Myeloma (RRMM)
Oncology·MeSH: Multiple Myeloma
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| sti-1492 | Sorrento Therapeutics, Inc. (SRNE) |
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Relapsed/Refractory Multiple Myeloma (RRMM)?
BioSniper tracks 2 drugs in development for Relapsed/Refractory Multiple Myeloma (RRMM) across 2 companies.
How many clinical trials target Relapsed/Refractory Multiple Myeloma (RRMM)?
There are 1 clinical trial targeting Relapsed/Refractory Multiple Myeloma (RRMM) tracked by BioSniper.
Deep-dive into Relapsed/Refractory Multiple Myeloma (RRMM)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis